Collaborative Drug Discovery - CDD Vault’s Post

Discovery chemists, ever dream of traveling from “data in” to “data out” along a path that includes entity registration? A DMTA workflow that saves you time and protects your investment? We've built the road. Meet some of its trailblazers on our July 31st webinar, including Steve Unger, Department Head and Director of Informatics at Pliant Therapeutics. Register for *Catalyzing DMTA Information into Insights* at https://lnkd.in/eBwDuFSw #medicinalchemistry #dmta #cheminformatics #drugdiscovery

We want to hear from you! Following a successful Integrated Drug Discovery Webinar on macrocycles, we’re planning future sessions – and we’d love your input! ➡️What topics would you like us to explore next in the world of drug discovery? Drop your suggestions in the comments or take a moment to share your thoughts through our quick survey here: https://lnkd.in/dAYMwYXb Your feedback will help us design webinars that provide the most value to you and your research. Let’s shape the future of IDD discussions together! #Pharmaron #DrugDiscovery #IDDWebinarseries #LifeSciences

Cold chain services for clinical trial success. Navigate the requirements of today’s complex and innovative therapeutics and the demands of the increasingly popular decentralized clinical trial models. From packaging to storage to distribution, each stage plays a critical role. Explore the cold chain solutions from Thermo Fisher Scientific, backed by 35+ years of cold chain experience. Access the interactive infographic: https://ow.ly/XOVm50RQP3Q. #ColdChainServices #ClinicalTrialSuccess #TherapeuticsInnovation #ColdChainSolutions #PharmaLogistics #SupplyChainManagement #ThermoFisherScientific

Dive into the art of making pivotal decisions in early drug discovery! Join us for an exclusive webinar with the authors of 'Making Good Decisions in Early Drug Discovery' featured in Nature Journal June, 2024. Discover the power of Decision Framing and how it can guide your team towards innovative strategies in the face of uncertainties. Don’t just make decisions—make the right ones. Register now: https://lnkd.in/eaiqBm4i #DecisionFrameworks #DrugDiscovery #StrategicDecisionMaking #Webinar

Are you ready to revolutionize your research? Join us for an exclusive webinar with Revvity!!🧬✨ Discover how RASTRUM’s cutting-edge 3D cell models can accelerate your drug discovery process and deliver more meaningful insights, faster than ever. Don’t miss the chance to see this game-changing technology in action! See details for registration below! Secure your spot now and take the next step in your research journey! 👩🔬👨🔬 #Webinar #3DCellCulture #OncologyResearch #RASTRUM #Inventia

Find out how Novartis is automating large molecule R&D with a fully integrated MS workflow. This webinar will explore how liquid handling systems, mass spectrometers, and the Genedata Biopharma platform come together to handle everything from sample prep to data reporting. Hear from Felix Stemmer and Martin Jockel as they share how automation is improving efficiency and supporting advanced analytics. Register now: https://lnkd.in/e5FHYKtX #MassSpectrometry #Biopharma #WorkflowAutomation

A key decision when considering #analyticaltestingmethods for #biotherapeutics is whether to pursue an in-house #assaydevelopment strategy or to adopt a commercial kit. This #infographic distills four illustrative case studies to explain the real-life pitfalls that may be encountered when pursuing an in-house #assay development strategy for #advancedtherapy product characterization. https://buff.ly/4e5ROIp Recently published content that covers the steps and challenges that go into in-house development of a #residualDNAassay in detail, and explores innovative research in this space, includes an #article and an on-demand #webinar Article: https://buff.ly/4deeh4F Webinar : https://buff.ly/4deehlb These are just a few of the resources available on our Characterization & Analytics Hub. The hub explores a new generation of analytical tools designed to meet the specific needs of #viralvector and cell-based therapy production, offering the enhanced speed, sensitivity, and robustness that the industry requires. Once you’ve read your first piece of content, all the rest is available to you open access Access the hub below: https://buff.ly/496Nshd

Dive into the art of making pivotal decisions in early drug discovery! Join us for an exclusive webinar with the authors of 'Making Good Decisions in Early Drug Discovery' featured in Nature Journal June, 2024. Discover the power of Decision Framing and how it can guide your team towards innovative strategies in the face of uncertainties. Don’t just make decisions—make the right ones. https://lnkd.in/eaiqBm4i #DrugDiscovery #StrategicDecisionMaking #Webinar

A key decision when considering #analyticaltestingmethods for #biotherapeutics is whether to pursue an in-house #assaydevelopment strategy or to adopt a commercial kit. This #infographic distills four illustrative case studies to explain the real-life pitfalls that may be encountered when pursuing an in-house #assay development strategy for #advancedtherapy product characterization. https://buff.ly/4e5ROIp Recently published content that covers the steps and challenges that go into in-house development of a #residualDNAassay in detail, and explores innovative research in this space, includes an #article and an on-demand #webinar Article: https://buff.ly/4deeh4F Webinar : https://buff.ly/4deehlb These are just a few of the resources available on our Characterization & Analytics Hub. The hub explores a new generation of analytical tools designed to meet the specific needs of #viralvector and cell-based therapy production, offering the enhanced speed, sensitivity, and robustness that the industry requires. Once you’ve read your first piece of content, all the rest is available to you open access Access the hub below: https://buff.ly/496Nshd

Find out how Novartis is automating large molecule R&D with a fully integrated MS workflow. This webinar will explore how liquid handling systems, mass spectrometers, and the Genedata Biopharma platform come together to handle everything from sample prep to data reporting. Hear from Felix Stemmer and Martin Jockel as they share how automation is improving efficiency and supporting advanced analytics. Register now: https://lnkd.in/ghwjaJFz #MassSpectrometry #Biopharma #WorkflowAutomation